Resources

Randomized Placebo-Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003900/

Learn more
Hashimoto’s encephalopathy: Follow-up data from neuropsychology, lumbar puncture, and FDG-PET February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745505/

Learn more
Antiepileptic drug therapy in autoimmune epilepsy associated with antibodies targeting the leucine-rich glioma-inactivated protein 1 February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119747/

Learn more
Autoimmune epilepsy: findings on MRI and FDG-PET February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435058/

Learn more
LGI1 expression and human brain asymmetry: insights from patients with LGI1-antibody encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156957/

Learn more
The short-term efficacy of combined treatments targeting B cell and plasma cell in severe and refractory Anti-N-methyl-D-aspartate receptor encephalitis: Two case reports February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436585/

Learn more
Intravenous immunoglobulin for the treatment of autoimmune encephalopathy in children with autism February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086890/

Learn more
Cognitive Function Recovery Pattern in Adult Patients With Severe Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Longitudinal Study February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109783/

Learn more
Encephalitis with mGluR5 antibodies February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980520/

Learn more
GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892043/

Learn more